SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zenotech Laboratorie reports Profit after tax of Rs 11.80 Mln, in the March 2021 quarter

01 May 2021 Evaluate
A decent increase of about 47.33% in the sales to Rs. 78.51 millions was observed for the quarter ended March 2021. The sales figure stood at Rs. 53.29 millions during the year-ago period.The Total Profit for the quarter ended March 2021 of Rs. 11.80 millions grew from Rs.-0.35 millionsOperating profit surged to 33.76 millions from the corresponding previous quarter of 14.29 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202103 202003 % Var 202103 202003 % Var 202003 201903 % Var
Sales 78.51 53.29 47.33 203.91 259.58 -21.45 259.38 130.29 99.08
Other Income 3.39 2.16 56.94 24.63 12.34 99.59 12.53 47.10 -73.40
PBIDT 33.76 14.29 136.25 67.88 101.51 -33.13 101.50 11.93 750.80
Interest 4.58 0.90 408.89 15.47 8.92 73.43 8.93 1.18 656.78
PBDT 29.18 13.39 117.92 52.41 156.29 -66.47 156.27 10.75 1353.67
Depreciation 17.38 13.74 26.49 64.56 48.50 33.11 48.50 42.02 15.42
PBT 11.80 -0.35 -3471.43 -12.15 107.79 -111.27 107.77 -31.27 -444.64
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 11.80 -0.35 -3471.43 -12.15 107.79 -111.27 107.77 -31.27 -444.64
Equity 610.31 610.31 0.00 610.31 610.31 0.00 610.31 610.31 0.00
PBIDTM(%) 43.00 26.82 60.36 33.29 39.11 -14.87 39.13 9.16 327.37

Zenotech Laboratorie Share Price

46.90 -0.10 (-0.21%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×